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ABSTRACT 
Background: Telomere length is associated with a large range of human diseases. Genome-
wide association studies (GWAS) have identified genetic variants that are associated with 
leucocyte telomere length (LTL). However, these studies are limited to adult populations. 
Nevertheless, childhood is a crucial period for the determination of LTL and the assessment 
of age-specific genetic determinants, although neglected, could be of great importance. Our 
aim was to provide insights and preliminary results on genetic determinants of LTL in 
children.  
Methods: Healthy children (n=322, age range=6.75 - 17 years) with available GWAS data 
(Illumina Human CNV370-Duo array) were included. The LTL was measured using 
multiplex quantitative real-time PCR. Linear regression models adjusted for age, gender, 
parental age at child’s birth and body mass index were used to test the associations of LTL 
with polymorphisms identified in adult GWAS and to perform a discovery-only GWAS.  
Results: The previously GWAS-identified variants in adults were not associated with LTL in 
our paediatric sample. This lack of association was not due to possible interactions with age 
or gene × gene interactions. Furthermore, a discovery-only GWAS approach demonstrated 6 
novel variants that reached the level of suggestive association (P ≤ 5 ×10-5) and explain a 
high percentage of children’s LTL.  
Conclusions: The study of genetic determinants of LTL in children may identify novel 
variants not previously identified in adults. Studies in large-scale children populations are 
needed for the confirmation of these results, possibly through a childhood consortium that 
could better handle the methodological challenges of LTL genetic epidemiology field.  
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INTRODUCTION 
Telomeres are structures made of tandem repeats of hexanucleotide units with telomeric-
interacting proteins that are present at the ends of chromosome and they are responsible for 
the protection of genomic integrity. The loss of several base pairs from telomeres during each 
mitotic division leads to telomere shortening which after a critical limit results in telomere 
dysfunction that triggers cell cycle arrest, apoptosis and/or cellular senescence 1. Leukocyte 
telomere length (LTL) has been correlated with a variety of human diseases such as cancer, 
cardiovascular diseases (CVDs) and CVD risk factors such as obesity, hypertension and 
diabetes 2.  
LTL is a highly heritable trait, as indicated by previous studies (40-80%) 3, 4 and verified in 
the most recent meta-analysis by Broer et al (70%) 5, and a number of genome-wide 
association studies (GWAS) have assessed its biological determinants 6-12. However, none of 
the studies included or referred to paediatric populations (<18 years). The rate of LTL 
attrition in infancy and early childhood is increased compared to adults, possibly due to 
increased growth rates 13. A plateau is observed between 4 years old and early adulthood, 
followed by a gradual decrease 14. Therefore, the study of genetic determinants of LTL in the 
age range of 4-18 years will likely identify the physiological factors that explain the high 
inter-individual variability of this trait. Furthermore, it is known that LTL attrition in 
adulthood is related to environmental factors such as obesity, smoking, inflammation and 
oxidative stress 15. In healthy children, many of these environmental factors are absent, thus 
increasing our confidence that novel genetic determinants of LTL, non-modified by 
environment, may arise from studies in similar populations compared to adults. To our 
knowledge, cohorts of healthy children with GWAS data and LTL measurements are limited. 
Therefore, our aim was to test the association of the GWAS-identified polymorphisms from 
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adult studies in a paediatric cohort, in order to assess their possible effect on this age group, 
and to seek for novel genetic determinants through a preliminary GWAS approach.  
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METHODS 
Subjects 
A group of unrelated children (age <18 years) was selected from the STANISLAS Family 
Study, a 10-year longitudinal cohort of 1,006 European families free of chronic disease 
(cardiovascular or cancer). All participants and their parents gave a written informed consent. 
Protocols were approved by the local ethics committees for the protection of subjects for 
biomedical research [Comité Consultatif de Protection des Personnes dans la Recherche 
Biomédicale (CCPPRB)]. For the present study, the inclusion criteria were based on normal 
weight [defined as body mass index (BMI) <97th percentile for age and sex according to 
French reference cohort 16] and complete availability of GWAS data and LTL measurements. 
The selection of normal weight children only was made with the purpose to avoid the effect 
of obesity and obesity-related factors to LTL 17. The final sample size consisted of 322 
children (age: 11.90±2.26 years, 50.6% males).  
 
Genotyping 
The genotyping was performed using the Illumina Human CNV370-Duo array, as previously 
described 18.  
 
LTL measurements 
The relative LTL was measured using monochrome multiplex quantitative real-time PCR 
(MM-qPCR) 19. This approach is used in human epidemiological studies, since large numbers 
of samples can be measured in a high-throughput and cost-effective way that uses minimal 
amounts of DNA. The telomere measurement values obtained using qPCR have been shown 
to correlate with the Southern blotting method, which is regarded as the ‘gold standard’ 
method, and are less expensive 20, 21. LTL measurements were carried out using the MM-
6 
 
qPCR method with minor modifications, as described in detail elsewhere 17. Briefly, all test 
samples were measured in duplicate, and five serial dilutions of the reference sample 
(leukocyte DNA from an adult female) spanning 5–50 ng were run in triplicate on each plate. 
The telomere amplicon signal (T) to single-copy gene control amplicon (S) ratios for each 
sample were calculated as T, the amount of reference DNA that matched the experimental 
sample for copy number of the telomere template, divided by S, that matched the copy 
number of the single-copy gene template. The mean coefficient of variation for the T/S 
measurements of duplicate samples was 4.5%. and the overall mean T/S ratio was 1.63±0.52. 
All T/S values were log-transformed before statistical analyses to ensure normal distribution 
of the data. As reported previously, and as expected, T/S measurements were negatively 
correlated with age (R= -0.17, P=0.002). 
 
Statistical analyses 
We tested the previous GWAS-identified single nucleotide polymorphisms (SNPs) from 
adults in our children cohort using a candidate-gene approach. We used a list of 14 SNPs 
summarized by the GWAS investigators HuGENavigator and the NHGRI Catalog of 
published GWAS (http://www.genome.gov/gwasstudies) for the telomere length trait and 7 
SNPs from the most recent GWAS meta-analysis 6 (table 1). Among these, 10 were 
genotyped in our GWAS array and for the rest, proxy SNPs were used (table 1). In total, 19 
polymorphisms were tested using linear regression models for the assessment of the 
associations with log-transformed T/S ratios, under an additive genetic model using PLINK, 
in a significance level of P ≤ 2.6 ×10-3. The gene × environment interactions were tested 
using similar linear regression models with the addition of the interaction term in a 
significance level of P ≤ 2.6 ×10-3. The epistatic interactions were tested using the BiForce 
toolbox, in a significance level of P ≤ 2.9 ×10-4. The genome-wide associations were tested 
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using linear regression models under an additive genetic model using PLINK (P = 5 × 10-8). 
Conditional analyses in order to test the independence of association between SNPs and LTL 
were also assessed. All models were adjusted for age, gender, parental age at child’s birth and 
BMI. Parental age has been shown to be inversely associated with LTL in children and was 
used as a covariate in the models 22. The levels of significance were calculated using the 
Bonferroni formula (P=α/n, where n is the number of tests for each stage). Power calculations 
were performed using QUANTO version 1.2.4.  
 
RESULTS AND COMMENTS 
Among the 19 polymorphisms, previously associated with LTL in adults, none was 
significantly associated with LTL in children. A possible explanation could be the effect of 
gene × age and gene × gene interactions that could mask the associations in childhood. 
However, no statistically significant interactions were observed either. Therefore, it seems 
that the genetic determinants of adults’ LTL do not affect the trait in childhood. It is, thus, 
possible that the identified variants in adults may be related to telomere maintenance during 
life, whereas, the genetic component of childhood LTL reflects the telomere length at birth. 
Hence, these findings support the notion that non-identified genetic variants determine LTL 
in children. Although the study was not sufficiently powered for the identification of low 
frequency polymorphisms with weak effects on LTL, it has an adequate power for more 
common variants and medium effects. Therefore, we would be expect to observe some 
significant results if these associations truly existed in children. Nevertheless, the interactions 
results should be considered with caution due to power issues.  
In order to further assess this idea, we also applied a GWAS approach in our population; 
however, due to the absence of other childhood studies with GWAS and LTL data we could 
only test our hypothesis in a GWAS discovery-only cohort.  
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In our discovery cohort, we did not identify any genome-wide significant associations. 
However, six SNPs reached the levels of suggestive association (P ≤ 5 ×10-5) and could be 
tested in replication studies and meta-analyses. Conditional analysis revealed that each of 
these SNPs was independently associated with log T/S ratio (P ≤ 4.6 ×10-4) (table 2). These 
SNPs have not been identified by GWAS in adult populations and this finding could support 
the hypothesis of differences in LTL genetic determinants between children and adults. 
Furthermore, these polymorphisms explain up to 23.9% of the variability of the phenotype in 
our sample (r2 calculated from linear regression model which includes only the 6 SNPs).  
Similarly to our study, previous GWAS on LTL in adults did not demonstrate genome-wide 
significant associations in their discovery cohorts 7, 8, 11, 12, indicating methodological 
challenges for the study of this trait. Our sample size, as well as the lack of a replication 
population, suggests a lack of statistical power. The study was sufficiently powered (>80%) 
to identify common variants (minor allele frequency, MAF >20%), with a relatively large 
effect (beta ≥ ±0.08) in a genome-wide significance level. However, these effect sizes are not 
the rule in LTL studies as indicated by the previous GWAS findings in adults (ranging from 
0.04-0.09 in the most recent study of Codd et al 6). This is a limitation of the study of LTL 
through GWAS and these possible associations should be replicated in larger GWAS on 
paediatric populations before any conclusions could be considered reliable. Furthermore, due 
to the limited longitudinal data regarding LTL attrition rate in childhood, we cannot exclude 
the presence of genetic variability in the age range of the group used in this study.  
LTL is a trait related to a large range of diseases and the identification of its genetic 
background is significant for the understanding of its dynamics and physiology and for the 
diseases prevention. The regulation of its levels during childhood is crucial and given its high 
heritable component, the determination of its genetic regulators in younger ages is of high 
significance. In this report, we have shown by a candidate-gene approach that the GWAS-
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identified markers in adults are not associated with LTL in children, and that this result is not 
due to gene × age or gene × gene interactions. This observation was also verified by a 
preliminary GWAS study. Our results, although of limited statistical power, suggest a 
differentiated genetic regulation of LTL between adults and children, as the six identified 
SNPs are novel and have not been demonstrated in previous adult studies. Nevertheless, these 
findings need to be re-assessed and replicated in larger childhood cohorts.  
Finally, we would like to stress the need for large consortia of investigators researching 
children with LTL data, which will likely be required to investigate this neglected and very 
challenging field of telomere biology research.  
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TABLES 
Table 1. GWAS-identified polymorphisms in adult populations and related proxies polymorphisms tested in the children cohort 
Polymorphism Closest genes Chra Reference Genotyped or proxy 
polymorphismb 
Rsquared 
rs2162440 BRUNOL4, 
PIK3C3 
18 Mangino et al 11 Yes  
rs12696304 TERC 3 Codd et al 8 rs1997392 1 
   Prescott et al J 12 1 
rs4452212 CXCR4 2 Levy et al 9 rs10221893 1 
rs2736428 SLC44A4 6 Yes  
rs1975174 ZNF676 19 rs11668269 1 
rs4387287 OBFC1 10 NAc  
rs6028466 DHX35 20 Gu e al 7 Yes  
rs398652 PELI2 14 Yes  
rs654128 KPNA5 6 Yes  
rs621559 WDR65 1 Yes  
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rs3027234 CTC1 17 Mangino et al 10 rs8075078 0.862 
rs412658 ZNF676 19 rs10419926 1 
rs1317082 TERC 3 rs10936599 1 
rs9419958 OBFC1 10 Yes  
rs10936599 TERC 3 Codd et al 6 Yes  
rs2736100 TERT 5  Yes  
rs7675998 NAF1 4  rs11100479 0.953 
rs9420907 OBFC1 10  Yes  
rs8105767 ZNF208 19  rs7257051 0.853 
rs755017 RTEL1 20  rs2281929 1 
rs11125529 ACYP2 2  rs11890390 0.932 
a Chr, chromosome, bYes, for polymorphisms genotyped in the Illumina Human CNV370-Duo array or rs number for proxy 
polymorphisms genotyped in the Illumina Human CNV370-Duo array, cNA, not genotyped and no available proxy polymorphism in 
the Illumina Human CNV370-Duo array 
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Table 2. Conditional analysis of the SNPs with suggestive GWAS association (P ≤ 5 ×10-5) 
Chra SNPb 
Minor 
allele 
MAFc PGWAS 
Location Conditional analysis 
Function Closest genes β (SE)d P 
2 rs10496920 G 0.18 5.00 ×10-5 Intergenic LRP1B/LOC100129955 0.05 (0.01) 4.60 ×10-4 
4 rs528983 G 0.11 2.93 ×10-5 Intron NDST4 -0.07 (0.01) 7.88 ×10-6 
6 rs594119 T 0.19 3.11 ×10-5 Intron NKAIN2 -0.05 (0.01) 2.19 ×10-5 
8 rs12678295 G 0.40 3.53 ×10-5 Intergenic MYOM2/CSMD1 -0.04 (0.01) 1.92 ×10-4 
21 rs2300383 G 0.47 1.88 ×10-5 Intron ITSN1 -0.04 (0.01) 7.42 ×10-6 
22 rs11703393 G 0.27 5.00 ×10-5 Intron PARVB -0.04 (0.01) 1.69 ×10-4 
aChr, chromosome, bSNP, single nucleotide polymorphism, cMAF, minor allele frequency, dβ, effect size; SE, standard error; β coefficient 
refers to log T/S ratio 
 
